middle.news
Racura Oncology Advances Lung Cancer Trials with Strong Cash Backing
9:28am on Thursday 30th of April, 2026 AEST
•
Healthcare
Read Story
Racura Oncology Advances Lung Cancer Trials with Strong Cash Backing
9:28am on Thursday 30th of April, 2026 AEST
Key Points
First patient enrolled in Phase 1 HARNESS-1 lung cancer trial
New blood-based test developed to monitor cardioprotective effects
Collaboration with Emory University on osimertinib-resistant lung cancer
Over 81% of quarterly spend directed to R&D and manufacturing
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Racura Oncology (ASX:RAC)
OPEN ARTICLE